Issue 015 | U.S. Pilot | US

ABOS

Acumen Pharmaceuticals, Inc.

Screen state: Passing Source state: Verified 10-Q | 2026-05-12 Filing currency: USD
Internal NCAV Discount 82.6%

GNNI internal NCAV discount calculation. Market context inputs are retained internally and are not displayed.

Current Assets
133,094,000USD
Total Liabilities
46,153,000USD
NCAV
86,941,000USD
Cash
51,796,000USD
NCAV per share
0.78USD/share
Evidence
5 annual | 24 quarterly

Mary filing review

Financial Statement Evidence

Deterministic observations from the frozen Mary Reason Card. They annotate filing evidence and do not determine screen inclusion.

Evaluated
12
Triggered
2
Unavailable
4
Requires inspection Negative OCF -24,128,000
Latest
-24,128,0002026-03-31
Comparison
n/a
Change
n/a

Basis: latest reporting-period cash from operations < 0

Source periods: SEC 10-Q 2026-03-31 · 0001628280-26-034204

Supporting observation Current Ratio > 1.5 4.55
Latest
4.552026-03-31
Comparison
1.5
Change
n/a

Basis: current assets / current liabilities; strong if > 1.5

Source periods: SEC 10-Q 2026-03-31 · 0001628280-26-034204

4 unavailable checks — inspect missing inputs
Material 1Y Share Increase 1Y share change >= +2% using the same share-count source
NCAV Growing equivalent prior-year NCAV change >= +2%; both NCAV values must be positive
No Material 1Y Share Increase 1Y share change > -2% and <= +1% using the same share-count source
Share Count Reduced 1Y share change <= -2% using the same share-count source

Business Profile

Checklist-driven facts extracted from filing text. Missing fields stay visible in the details.

business_profile_v1

Business profile: 0 of 12 fields established by the current extractor.

Business Profile Field Details

Business Description

Missing Source

Not established by the current extractor from the selected filing context.

Revenue Model

Missing Source

Not established by the current extractor from the selected filing context.

Customers And Channels

Missing Source

Not established by the current extractor from the selected filing context.

Segments And Geography

Missing Source

Not established by the current extractor from the selected filing context.

Tangible Operations Assets

Missing Source

Not established by the current extractor from the selected filing context.

Value Chain

Missing Source

Not established by the current extractor from the selected filing context.

Competition Positioning

Missing Source

Not established by the current extractor from the selected filing context.

Business Lifecycle Cyclicality

Missing Source

Not established by the current extractor from the selected filing context.

Strategy And Capital Allocation

Missing Source

Not established by the current extractor from the selected filing context.

Management Governance Signals

Missing Source

Not established by the current extractor from the selected filing context.

Disclosed Risks

Missing Source

Not established by the current extractor from the selected filing context.

Known Unknowns

Missing Source

Not established by the current extractor from the selected filing context.

Business Profile Sources
Source Filing Date Type Status Provenance
S1 0001576885-25-000104 2025-11-12 10-Q Missing Source Data Vault | sec/cleaned/cik=0001576885/accession=0001576885-25-000104/parser=html-cleaner-v1/full.txt
Share Count & Per-Share Comparability

Data Vault has not published the normalized share-count artifact for this company.

Known Unknowns

Medium | Share Count

The current U.S. Pilot does not yet evaluate share-count trends or post-filing dilution beyond Mary's screening flags.

Low | Classification

U.S. Pilot rows are surfaced for source inspection and may still need manual business classification review.

Annual Financials

Latest annual periods, newest first. Missing cells render as n/a.

Metric
2025-12-31
10-K
USD
2024-12-31
10-K
USD
2023-12-31
10-K
USD
2022-12-31
10-K
USD
2021-12-31
10-K
USD
Revenue n/a n/a n/a n/a n/a
Operating Income -123,832,000 -114,017,000 -61,138,000 -45,237,000 -19,584,000
Net Income -121,335,000 -102,329,000 -52,371,000 -42,856,000 -100,606,000
Cash From Operations -115,538,000 -86,215,000 -43,064,000 -35,153,000 -17,961,000
Capex -88,000 -16,000 -21,000 -161,000 -40,000
Free Cash Flow -115,626,000 -86,231,000 -43,085,000 -35,314,000 -18,001,000
Cash And Equivalents 53,989,000 35,627,000 66,886,000 130,101,000 122,162,000
Accounts Receivable n/a n/a n/a n/a n/a
Inventory n/a n/a n/a n/a n/a
Total Current Assets 122,252,000 178,306,000 246,615,000 180,329,000 198,661,000
Total Assets 122,833,000 238,992,000 310,125,000 196,587,000 230,330,000
Total Current Liabilities 30,007,000 27,607,000 12,971,000 7,812,000 5,147,000
Total Liabilities 52,403,000 57,176,000 43,152,000 7,812,000 5,147,000
Shareholders Equity 70,430,000 181,816,000 266,973,000 188,775,000 225,183,000
Shares Outstanding 72,212,758 60,573,425 60,079,778 41,025,062 40,473,270
Shares Outstanding Diluted n/a n/a n/a n/a n/a
Weighted Avg Shares Diluted 60,561,836 60,013,277 48,609,383 40,601,936 20,057,534
Weighted Avg Shares Basic 60,561,836 60,013,277 48,609,383 40,601,936 20,057,534
Net Share Count Change (Normalized) Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence
Ownership Claim Change (Normalized) Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence
Quarterly Financials

Latest quarterly periods, newest first. Periods are shown only when Data Vault has them.

Metric
2026-06-30
10-Q
USD
2026-03-31
10-Q
USD
2025-12-31
10-K
USD
2025-12-31
10-K
USD
2025-09-30
10-Q
USD
2025-06-30
10-Q
USD
2025-03-31
10-Q
USD
2024-12-31
10-K
USD
2024-12-31
10-K
USD
2024-09-30
10-Q
USD
2024-06-30
10-Q
USD
2024-03-31
10-Q
USD
2023-12-31
10-K
USD
2023-12-31
10-K
USD
2023-09-30
10-Q
USD
2023-06-30
10-Q
USD
2023-03-31
10-Q
USD
2022-12-31
10-K
USD
2022-12-31
10-K
USD
2022-09-30
10-Q
USD
2022-06-30
10-Q
USD
2022-03-31
10-Q
USD
2021-09-30
10-Q
USD
2021-06-30
10-Q
USD
Revenue n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Income -32,556,000 -21,149,000 -25,199,000 -25,199,000 -26,513,000 -41,750,000 -30,370,000 -39,597,000 -39,597,000 -32,265,000 -24,381,000 -17,774,000 -18,486,000 -18,486,000 -16,039,000 -13,478,000 -13,135,000 -14,248,000 -14,249,000 -11,371,000 -10,411,000 -9,206,000 -3,935,000 -3,441,000
Net Income -32,718,000 -20,737,000 -25,138,000 -25,138,000 -26,451,000 -40,950,000 -28,796,000 -37,154,000 -37,154,000 -29,765,000 -20,537,000 -14,873,000 -16,497,000 -16,497,000 -12,957,000 -11,610,000 -11,307,000 -12,866,000 -12,866,000 -10,710,000 -10,151,000 -9,129,000 -3,902,000 -61,358,000
Cash From Operations -18,075,000 -24,128,000 -19,096,000 -19,096,000 -30,489,000 -31,832,000 -34,121,000 -27,215,000 -27,215,000 -24,596,000 -16,545,000 -17,859,000 -8,314,000 -8,314,000 -12,905,000 -11,670,000 -10,175,000 -11,203,000 -11,203,000 -9,183,000 -6,468,000 -8,299,000 -7,688,000 n/a
Capex 0 0 n/a 0 0 -9,000 -79,000 n/a 0 0 -5,000 -11,000 n/a -14,000 -7,000 0 0 n/a -35,000 -81,000 -36,000 -9,000 -8,000 n/a
Free Cash Flow -18,075,000 -24,128,000 n/a -19,096,000 -30,489,000 -31,841,000 -34,200,000 n/a -27,215,000 -24,596,000 -16,550,000 -17,870,000 n/a -8,328,000 -12,912,000 -11,670,000 -10,175,000 n/a -11,238,000 -9,264,000 -6,504,000 -8,308,000 -7,696,000 n/a
Cash And Equivalents 59,443,000 51,796,000 53,989,000 53,989,000 46,832,000 36,810,000 30,159,000 35,627,000 35,627,000 33,184,000 67,955,000 46,930,000 66,886,000 66,886,000 94,917,000 77,248,000 77,999,000 130,101,000 130,101,000 157,540,000 111,067,000 108,764,000 135,802,000 68,812,000
Total Current Assets 115,513,000 133,094,000 122,252,000 122,252,000 132,153,000 148,404,000 154,947,000 178,306,000 178,306,000 207,632,000 266,915,000 255,831,000 246,615,000 246,615,000 218,598,000 149,538,000 144,032,000 180,329,000 180,329,000 202,560,000 191,053,000 192,098,000 204,913,000 70,572,000
Total Liabilities 58,744,000 46,153,000 52,403,000 52,403,000 49,048,000 54,820,000 48,957,000 57,176,000 57,176,000 49,773,000 44,966,000 38,933,000 43,152,000 43,152,000 6,098,000 8,531,000 8,779,000 7,812,000 7,812,000 6,613,000 5,159,000 3,998,000 1,489,000 4,518,000
Shares Outstanding 72,317,285 72,227,580 60,575,369 72,212,758 60,573,425 60,573,425 60,573,425 60,094,083 60,573,425 60,079,778 60,079,778 60,079,778 57,910,461 60,079,778 57,910,461 57,868,512 41,025,062 41,025,062 41,025,062 40,925,284 40,503,124 40,501,258 40,470,323 40,468,087
Shares Outstanding Diluted n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Weighted Avg Shares Diluted 72,250,694 63,219,289 n/a 60,574,205 60,573,425 60,573,425 60,525,628 n/a 60,080,087 60,079,778 60,079,778 59,812,000 n/a 57,910,463 54,229,630 41,025,062 41,025,062 n/a 40,930,590 40,502,860 40,497,087 40,473,270 38,266,593 432,325
Weighted Avg Shares Basic 72,250,694 63,219,289 n/a 60,574,205 60,573,425 60,573,425 60,525,628 n/a 60,080,087 60,079,778 60,079,778 59,812,000 n/a 57,910,463 54,229,630 41,025,062 41,025,062 n/a 40,930,590 40,502,860 40,497,087 40,473,270 38,266,593 432,325
Net Share Count Change (Normalized) Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence
Ownership Claim Change (Normalized) Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence Insufficient evidence
Audit Trail

NCAV Audit

Official-source inputs remain linked to filing provenance. Derived values are labeled as such.

Input Value Source concept Filing period Confidence Provenance
Current Assets 115,513,000USD us-gaap:AssetsCurrent 2026-06-30 1.00 Data Vault | sec/companyfacts/cik=0001576885/companyfacts.json
Data Vault | sec/companyfacts/cik=0001576885/companyfacts.json
Total Liabilities 58,744,000USD us-gaap:Liabilities 2026-06-30 1.00 Data Vault | sec/companyfacts/cik=0001576885/companyfacts.json
Data Vault | sec/companyfacts/cik=0001576885/companyfacts.json
Cash 59,443,000USD us-gaap:CashAndCashEquivalentsAtCarryingValue 2026-06-30 1.00 Data Vault | sec/companyfacts/cik=0001576885/companyfacts.json
Data Vault | sec/companyfacts/cik=0001576885/companyfacts.json
Shares Outstanding 72,317,285 dei:EntityCommonStockSharesOutstanding 2026-06-30 1.00 Data Vault | sec/companyfacts/cik=0001576885/companyfacts.json
Data Vault | sec/companyfacts/cik=0001576885/companyfacts.json
NCAV 56,769,000USD derived 2026-06-30 n/a company-evidence-v1 | total_current_assets - total_liabilities
NCAV per share 0.78USD derived 2026-06-30 n/a company-evidence-v1 | NCAV / shares_outstanding
Internal NCAV Discount 82.6% derived 2026-06-30 n/a gnni_publication_pack | internal_discount

NCAV = total_current_assets - total_liabilities | NCAV per share = NCAV / shares_outstanding

Source Provenance

Data Source
Data Vault
Data Vault Root
Local evidence | The Data Vault
CIK
0001576885
Company ID
n/a
Selected Annual Source
Data Vault | sec/companyfacts/cik=0001576885/companyfacts.json
Selected Quarterly Source
Data Vault | sec/companyfacts/cik=0001576885/companyfacts.json
Statement Extractor
companyfacts-screener-v1
View Extractor
companyfacts-screener-v1
Source Accession Count
22
Imported At
2026-11-01T11:32:06+00:00
Rendered At
2026-11-01T14:57:29+00:00

Run Audit

Mary Run
96f10914845d4a63bf1f2ca5985451b2
Mary As Of
2026-10-30
Accession
0001628280-26-034204
CIK
0001576885
Mary Filing Date
2026-05-12
Filing Currency
USD
Internal Discount
82.6%
Source State
Verified
Market Context
Not Displayed
Market Policy
internal_only_not_redistributed
Share Trend
Not Evaluated
Dilution
Needs Review

mary_run=96f10914845d4a63bf1f2ca5985451b2; mary_as_of=2026-10-30; mary_filing_date=2026-05-12; mary_accession=0001628280-26-034204; mary_cik=0001576885; gnni_supporting_filing_date=2026-05-12; internal_discount=0.825539; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.

Back to Register Report a correction Archive